hydrazine has been researched along with Tuberculosis, Drug-Resistant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chelnokova, OG; Kibrik, BS; Pavlov, AV | 1 |
| Foks, H; Gobis, K; Główka, ML; Kałużyńska, S; Mazerant, I; Olczak, A; Szczesio, M | 1 |
| Bai, Y; Hu, Z; Li, J; Lu, J; Luo, R; Tang, Z; Wang, H; Wu, J; Xian, Q; Yue, J; Zhang, X | 1 |
3 other study(ies) available for hydrazine and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
[Bacteriological substantiation of the antituberculosis effect of immunotropic drug tubosan].
Topics: Adjuvants, Immunologic; Antitubercular Agents; Case-Control Studies; Humans; Hydrazines; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Pyrimidines; Russia; Sulfones; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Planarity of benzoyldithiocarbazate tuberculostatics. II. Diesters of benzoyldithiocarbazic acid.
Topics: Antitubercular Agents; Crystallography, X-Ray; Hydrazines; Hydrogen Bonding; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Tuberculosis, Multidrug-Resistant | 2016 |
In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line, Tumor; Colony Count, Microbial; Drug Evaluation, Preclinical; Female; Haplorhini; Humans; Hydrazines; Isoniazid; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolones; Spleen; Survival Analysis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2010 |